Mitometh Uses, Dosage, Side Effects and more
Mitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others. Mitometh has been investigated for the treatment of Lung Neoplasms, Untreated Childhood Medulloblastoma, and Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor.
| Attribute | Details |
|---|---|
| Trade Name | Mitometh |
| Generic | Mitometh |
| Type | |
| Formula | C15H12Cl4 |
| Weight | Average: 334.06 Monoisotopic: 331.9693112 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
